BioLife Solutions (BLFS) Stock: Buy, Sell, or Hold?
BLFS - BioLife Solutions Inc.
$38.61
1.31 (3.51%)
â˛
5d:
-1.38%
30d:
+8.67%
90d:
+38.24%
WAIT
LOW Confidence
Analysis Updated: Oct 5, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When BLFS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: BLFS is fairly priced but lacks strong directional signals. At 2.5% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: BLFS is fairly priced but lacks strong directional signals. At 2.5% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.07
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$9.98
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLFS is currently trading at $38.61, which is considered slightly high relative to its 30-day fair value range of $36.46 to $38.72. The stock's valuation (Forward PE: 117.0) is in line with its historical norms (108.6). At these levels, the market is pricing in 2.5% annual earnings growth.
Technical Outlook: Technically, BLFS is in a strong uptrend. The price is approaching resistance at $39.76. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: BLFS scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $31.29. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BLFS is in a strong uptrend. The price is approaching resistance at $39.76. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: BLFS scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $31.29. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$36.46 -
$38.72
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.7%
Protect Your Profits
Holding BLFS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (31/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.5%)
- BEARISH: Trading 19.0% above Wall St target ($31.29)
- BULLISH: Expecting earnings turnaround to 2.5% growth with 21.5% revenue growth
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$36.46 -
$38.72
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
Âą$2.29
(5.9%)
Support & Resistance Levels
Support Level
$36.70
Resistance Level
$39.76
Current Trend
Strong Uptrend
Technical data as of
Oct 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
117.00
Wall Street Target
$31.29
(-19.0%)
Revenue Growth (YoY)
21.5%
Earnings Growth (YoY)
-13.9%
Profit Margin
54.4%
Valuation Premium vs History
+2.5% premium
PE vs Historical
117.0 vs 108.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.5%
(market-implied from PE analysis)
1-Year Target
$39.58
(+3%)
2-Year Target
$40.56
(+5%)
3-Year Target
$41.58
(+8%)
3-Yr Target (if PE normalizes)
(PE: 117â109)
PE COMPRESSION
$38.59
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 117.0, Growth: 32.0%)
$88.80
(+130%)
Base:
(SPY PE: 19.7, Growth: 32.0%)
$14.95
(-61%)
Bear:
(PE: 16.7, Growth: 32.0%)
$12.71
(-67%)
Share & Embed Analysis
Last updated: October 22, 2026 5:34 PM ET
Data refreshes hourly during market hours. Next update: 6:34 PM
Data refreshes hourly during market hours. Next update: 6:34 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLFS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$479 | 32 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$83 | 37 SELL |
|
RGEN
Repligen Corporation |
STRONG BUY
22 analysts |
$198 | 49 HOLD |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
17 analysts |
$413 | 41 HOLD |
|
STVN
Stevanato Group SpA |
BUY
14 analysts |
$24 | 63 BUY |
Advanced BLFS Option Strategies
Professional options setups generated by AI based on today's BLFS price and gamma walls.
